| Literature DB >> 31366028 |
Zahra Hajiahmadi1,2, Ali Movahedi3, Hui Wei1, Dawei Li1, Yasin Orooji4, Honghua Ruan1, Qiang Zhuge1.
Abstract
The CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeat-associated protein 9) is a powerful genome-editing tool in animals, plants, and humans. This system has some advantages, such as a high on-target mutation rate (targeting efficiency), less cost, simplicity, and high-efficiency multiplex loci editing, over conventional genome editing tools, including meganucleases, transcription activator-like effector nucleases (TALENs), and zinc finger nucleases (ZFNs). One of the crucial shortcomings of this system is unwanted mutations at off-target sites. We summarize and discuss different approaches, such as dCas9 and Cas9 paired nickase, to decrease the off-target effects in plants. According to studies, the most effective method to reduce unintended mutations is the use of ligand-dependent ribozymes called aptazymes. The single guide RNA (sgRNA)/ligand-dependent aptazyme strategy has helped researchers avoid unwanted mutations in human cells and can be used in plants as an alternative method to dramatically decrease the frequency of off-target mutations. We hope our concept provides a new, simple, and fast gene transformation and genome-editing approach, with advantages including reduced time and energy consumption, the avoidance of unwanted mutations, increased frequency of on-target changes, and no need for external forces or expensive equipment.Entities:
Keywords: CRISPR; Cas9; aptazyme; off-target effect; on-target mutation
Year: 2019 PMID: 31366028 PMCID: PMC6696359 DOI: 10.3390/ijms20153719
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
List of some recent CRISPR studies in different plants considering the transformation method.
| Plant Species | sgRNA Promoter | Cas9 or Cpf1 Promoter | Off-Target Mutation (%) | On-Target Effects (%) | Transformation Method/Off-Target Decreasing Strategy | Reference |
|---|---|---|---|---|---|---|
|
| AtU6 | 35DPPDK | Not detected | 1.1–5.6 | Protoplast transfection/highly specific sgRNA | [ |
| AtU6 | AtRPS5a | <0.1 | 85 | [ | ||
| AtU6 | CaMV35S | N/A | 6.5 | Protoplast transfection/- | [ | |
| AtU6 | AtYAO | Not detected | 86 | [ | ||
| AtU626 | 2 X CaMV35S | Not detected | 24 | [ | ||
|
| OsU3 | CaMV35S | N/A | 7.3 | Protoplast transfection/- | [ |
| OsU6 | 2 X CaMV35S | Not detected | 8 | Particle bombardment transformation/Cpf1 | [ | |
| OsU3 | CaMV35S | Not detected | 5 | Particle bombardment transformation/highly specific sgRNA | [ | |
| OsU3 | ZmUbi | 0–2.2 | 85 | [ | ||
| OsU3 | ZmUbi | N/A | 90.6 | Particle bombardment transformation/ dual sgRNAs-Cas9 vector | [ | |
| OsU3 | ZmUbi | N/A | 75 | [ | ||
|
| AtU6 | Ubi | Not detected | 5.3–100 | [ | |
| AtU6-26 | CaMV35S | N/A | 0–54.5 | [ | ||
|
| - | - | Not detected | 0.09–2.25 | Protoplast transfection/RNPs | [ |
| AtU6-26 | PcUbi4-2 | Not detected | 100 | [ | ||
|
| OsU3 | ZmUbi | Not detected | 90–100 | [ | |
| ZmU6 | ZmUbi | Not detected | 10.67 | [ | ||
| - | - | Not detected | 47 | Protoplast transfection/RNPs | [ | |
| ZmU3 | ZmUbi | Not detected | 10 | [ | ||
|
| TaU3 | Rice Actin | Not detected | 11–17 | [ | |
| CaMV35S | CaMV35S | Not detected | 18–22 | [ | ||
| - | - | 5.7 | 21.8–33.4 | Protoplast transfection/RNPs | [ | |
| TaU6 | ZmUbi | Not detected | 1 | Particle bombardment transformation/Cas9 nickase- cytidine deaminase fusion | [ | |
|
| AtU3b | 2 X CaMV35S | Not detected | 31 | [ | |
| - | - | Not detected | 0.1 | Protoplast transfection/RNPs | [ | |
| AtU6 | CaMV35S | Not detected | Up to 100 | [ | ||
|
| AtU6-26 | SIUbi10 | N/A | Up to 90 | [ | |
| AtU6-26 | 2 X CaMV35S | Not detected | Up to 100 | [ | ||
| AtU6-26 | PcUbi4-2 | Not detected | Up to 71 | [ | ||
| AtU6 | 2 X CaMV35S | Not detected | 72.7–100 | [ | ||
| AtU6 | 2xCaMV35S | N/A | 75–100 | [ | ||
|
| - | - | Not detected | 0.5–6.9 | Protoplast transfection/RNPs | [ |
| AtU6-1 | 2 X CaMV35S | Not detected | 31.8 | [ | ||
|
| AtU6 | 35DPPDK | Not detected | 37.7–38.5 | Protoplast transfection/highly specific sgRNA | [ |
| AtU6 | CaMV35S | Not detected | 1.8–2.4 | [ | ||
| CaMV35S | CaMV35S | Not detected | 0–12.7 | [ | ||
|
| AtU3b | CaMV35S | N/A | 51.7 | [ | |
| MtU6-6 | CaMV35S | Not detected | 100 | [ | ||
|
| AtU6 | Ubi | Not detected | 2.2 | [ | |
|
| MtU6 | 2 X CaMV35S | Not detected | 10.4 | [ | |
|
| AtU6-26 | CaMV35S | Not detected | 27 | [ |
-: No special method has been used to decrease off-target effects; N/A: Not available; RNP: CRISPR/Cas9 or CRISPR/Cpf1 ribonucleoproteins.
Figure 1Schematic diagram of the ribozyme-flanked artificial sgRNA (RGR). (A) An RGR construction (P: Any promoter; T: Terminator; Ribozyme: Self-cleaving ribozyme; and sgRNA: Single guide RNA); (B) Transcription of the sgRNA by RNA polymerase II (Pol II) causes changes in the primary transcript, including 5′-end capping and 3′-end poly A tail; (C) Transcription of the sgRNA by RNA polymerase III (Pol III) causes changes in the primary transcript, including 3′-end poly U tail; and (D) Ribozymes cleave the 5′-end and 3′-end modifications and produce the unchanged sgRNAs.
Figure 2Schematic diagram of sgNA/ligand-dependent ribozymes. (A) The ligand-dependent ribozymes (AZ) are inserted into the sgRNA stem-loop structures; and (B) in the presence of the ligand, the AZ cleaves itself which leads to the sgRNA degradation.
Figure 3Schematic diagram of the best combination method to avoid off-target mutations in plants. (A1,A2) Positive charged mesoporous silica nanoparticles (MSNs) and plasmid (pDNA), respectively; (A3) the MSNs containing the pDNA; (B1–B3) three different pDNA-MSNs transient (injection pDNA-MSNs complex into the abaxial surface of leaf) and stable transformation (plant tissue culture and injection pDNA-MSNs complex into the ovary of flower) methods under the temperature of 37 °C, respectively; (C1) sgRNA-aptazyme (AZ) finds a homologous target gene and Cas9 cleaves the target; (C2,C3) in the presence of the ligand, the AZ cleaves itself that leads to the sgRNA degradation; and (C4) finally, using several molecular techniques for detection the on-target and the off-target mutations.